Autonomix Medical ( NASDAQ: AMIX ) announces the changes to its executive leadership team with the appointment of Brad Hauser as President and CEO and Lori Bisson, former President and CEO, as Executive Vice Chairman of the Board. The move comes with the aim of supporting its next pivotal phase of development. Hauser most recently served as the Chief Operating Officer at Beauty Health, a global category-creating company delivering millions of skin health experiences every year.
In connection with Hauser's appointment, the board approved an inducement stock option to purchase 900,000 shares of the company’s common stock. The options have a ten-year term and vest in four equal annual installments. Shares of AMIX were down 2.
14% in premarket trading on Tuesday. More on Autonomix Medical: Autonomix announces positive preclinical study for its catheter-based sensing technology Financial information for Autonomix Medical, Inc..
